This inventor holds 1 USPTO granted patent. Top assignees: Industry-University Cooperation Foundation Hanyang University, Korea Institute of Science and Technology. Active years: 2019.
Company Filing History:
1 out of 1,229 
1 out of 2,248 
Years Active: 2019
Title: Byeong Yun Lim: Innovator in Anticancer Research
Introduction
Byeong Yun Lim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anticancer properties. His work is characterized by a commitment to advancing therapeutic options for tumor diseases.
Latest Patents
Lim holds a patent for a novel pyrimidine-4-carboxylic acid derivative that exhibits anticancer activity. This compound is recognized for its potential utility as a drug for treating and preventing tumor diseases. The patent highlights the innovative nature of his research and its implications for cancer treatment.
Career Highlights
Throughout his career, Byeong Yun Lim has been associated with prominent institutions such as the Industry-University Cooperation Foundation at Hanyang University and the Korea Institute of Science and Technology. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Lim has worked alongside notable colleagues, including Seung Hye Choi and Tae Bo Sim. These collaborations have enriched his research and expanded the impact of his innovations in the field of anticancer drug development.
Conclusion
Byeong Yun Lim's contributions to anticancer research through his innovative patent and collaborations with esteemed colleagues underscore his role as a significant figure in the scientific community. His work continues to inspire advancements in cancer treatment.